Healthcare Analytics Market To Observe Strong Development By 2024

 Global healthcare analytics market size is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 12,126.70 million in 2018 and is projected to grow at a CAGR of 27.1% over the forecast period. Healthcare analytics is one of the major segment of analysis that primarily focuses on providing insights into hospital management, costs, patient records, diagnoses, and various other data. The field covers all the segments of the healthcare industry, providing insights on both the macro and micro level. The global healthcare/medical analytics market growth is expected to grow at a rapid pace due to factors such as high adoption of technological advancements in the field of healthcare, increasing demand for reducing paperwork, better treatment plans in collaboration with pharmaceutical organizations, increasing availability of low cost technology, to improve patient care efforts, better services, and improve existing procedures.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7819

For improve, treatment plans in association with pharmaceutical organizations are one of the major factors for analytics-driven revolution in healthcare. With more access to wide and in-depth information, pharmaceutical organizations can come up with better formulations for diseases. With the help of more data and analytics, pharmaceutical organizations will be able to assure their formulations positively. This will eventually move the trend from volume discounts to evidence-based outcome models. However, with these advantages of healthcare analytics driving the growth of the market, few restraints are hampering the growth of the market including; data security, high cost of analytical solutions, and technology challenged the user.   

Healthcare Analytics Market Segmentation

The global healthcare/medical analytics market has been segmented into type, component, delivery model, application and end user.

Based on type, market segmented into descriptive analytics, predictive analytics, prescriptive analytics, and cognitive analytics.

Based on component, market segmented into software, hardware, and services.

Based on delivery mode, market segmented into on-premise and on-demand.

Based on application, the healthcare/medical analytics market is segmented into Financial Analytics (Claims Processing, Revenue Cycle Management (RCM), Payment Integrity & Fraud, Waste, and Abuse (FWA), Risk Adjustment & Assessment), Clinical Analytics (Quality Improvement & Clinical Benchmarking, Clinical Decision Support (CDS)), operational & administrative analytics, population health analytics

Based on end user, healthcare analytics market segmented into Payers (Private Insurance Companies, Government Agencies, Employers and Private Exchanges), Providers (Hospitals & Clinics, Post-Acute Care Organizations, Ambulatory Settings), Others.

The global healthcare analytics market by region has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Healthcare Analytics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Healthcare Analytics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The Healthcare Analytics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Healthcare Analytics market in the Middle East & Africa has been segmented into the Middle East and Africa.

 Healthcare Analytics Market Key players

Some of the prominent players in the global Healthcare/Medical Analytics market are Cerner, Allscripts Healthcare Solutions, SAS Institute Inc., IBM, Wipro, Inovalon, Cotiviti, Citiustech, Health Catalyst, Mckesson, Optum, Oracle, SCIO Health Analytics, Vitreoshealth, Medeanalytics, Others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-analytics-market-7819

Current And Forthcoming Stethoscope Market Size In Terms Of Volume And Value 2024

 The global stethoscope market is expected to grow significantly over the forecast period. It is estimated that the global stethoscope market is expected to register a CAGR ~ 4.6% during the forecast period of 2019 to 2024 with an estimated market value of USD 332.1 million in 2018.

The global market is driven by factors such as increasing incidence rate of life-threatening diseases, increased spending on healthcare and ongoing research and development. Moreover, growing technological advancements such as Bluetooth connectivity with digital wireless hearing aids is expected to fuel the growth of the market during the assessment period. Furthermore, increasing innovations in the field of healthcare have pushed for the growth of the market. For instance, in October 2018, researchers from Rochester Institute of Technology and University of Rochester Medical Center developed a new electronic stethoscope that combines precision sensors, electrocardiogram technology, and machine learning applications into one piece of equipment to better detect heart ailments and problems that might occur with an implanted heart pump. Similarly, in March 2018, Neurologists from Stanford University developed brain stethoscope that can translate the brain’s activity into sounds so that silent seizures can be detected. On the other hand, poor healthcare system and less access to health services in certain economies are restraining the growth of stethoscope market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7802

Moreover, major companies in the market are involved in strategic collaborations to brace their position in the market. For instance, in September 2015, eKuore launched its first wireless stethoscope in Düsseldorf, Germany. 

Segmentation

The global stethoscope market has been segmented into type, and end user. The market, based on type, has been segmented into manual stethoscope and electronic stethoscope. The market, by manual stethoscope, has been further segmented into a fetal stethoscope, and others. The market, by electronic stethoscope, has been sub-segmented into esophageal stethoscopes, fetal heart rate detectors, and others. The market, by end user, has been segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are expected to hold a major share in the end user segment owing to the increased occurrences of diseases, as well as the rise in the patient visits. Clinics are projected to be the fastest growing segment due to the ease of accessibility it provides to the patients.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The stethoscope market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European stethoscope market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The stethoscope market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The stethoscope market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

3M, A&D Medical, American Diagnostic Corporation, Cardionics, GF Health Products, Heine Optotechnik, McCoy Medical, Medline Industries, Omron Corporation, Rudolf Riester, Smith’s Medical, and Welch Allyn are some of the key players in the global stethoscope market.

Regional Market Summary

Geographically, the Americas is expected to dominate the global stethoscope market due to the increasing per capita healthcare expenditure. The rise in product innovation and the heavy adoption of new technology is anticipated to drive the growth of the market.

Europe showed a considerable amount of growth in the global stethoscope market. The market growth in this region is because of the presence of a well-established healthcare system. The rise in the patient population is also contributing to the growth in the region.

Asia-Pacific is estimated to be the fastest growing region in the market due to a rise in the number of health welfare programs. This growing awareness in Asian countries by public and private organizations is projected to fuel the growth of the market during the assessment period. On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/stethoscope-market-7802

Hepatitis B Treatment Market To Observe Strong Development By 2024

 The global hepatitis B treatment market is expected to register an approximate CAGR of 5.3% during the forecast period, i.e., from 2018 to 2024.

Hepatitis is a viral infection caused by Hepatitis A, B or C virus. The infection results to cause liver infection or inflammation and many times leading to liver damage.

Hepatitis B virus spreads through coming in contact with infected blood, drinking contaminated water, and using infected needles or syringes.  The person suffering from Hepatitis B faces various symptoms such as poor appetite, weakness, jaundice, dark-colored urine, itching on skin, swelling on legs, weight loss, drowsiness and many more. According to the World Health Organization 2018 fact sheet, it was estimated that 257 million people across the world have lived with hepatitis B infection and also mentioned that around 887,000 number of people died from hepatitis B in 2015. Thus, the increasing prevalence of Hepatitis B across the world boosts market growth.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7817

However, the factors such as side effects associated with treatment and medications hinder the market growth.

Hepatitis B Treatment Market Segmentation

 

The global hepatitis B treatment market is segmented on the basis of type, treatment, distribution channel, and region.

Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global hepatitis B treatment market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery  (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.

Based on region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Hepatitis B Treatment Market Key players

 

Some of the key players in the global hepatitis B treatment market are Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Arrowhead Pharma, Aurobindo Pharma Limited, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline, Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Par Pharmaceutical, Inc., Teva Pharmaceuticals, Zydus Pharmaceuticals, and Others.

Hepatitis B Treatment Regional Market Summary

Sources: Centers for Disease Control and Prevention, GOV.UK, Society of Cardiovascular Computed Tomography, Indian Brand Equity Foundation, Annual Reports, Press Release, White Paper, And Company Presentation

The Americas dominates the global market for hepatitis B treatment owing to the increasing bacterial infection, development in the clinical practices, and availability and access of best treatments for viral infection in this region.

Moreover, high healthcare expenditure within the Americas boosts the regional market. According to the National Vaccine Information Center, there were 3,370 acute cases of hepatitis B in the US in 2015. Following similar trends, Europe stood second in the global hepatitis B treatment market. On a regional basis, the European market is segmented into Western Europe and Eastern Europe. Europe is estimated to lead the market due to the presence of advanced medical facilities and rising viral infection among the population contributes to increasing the new cases of hepatitis B among the population. According to the World Health Organization data sheet, hepatitis B and C affects a large number of people in the European region. It also, stats that globally, 1.5 million people die every year because of hepatitis B virus. The increasing incidences of hepatitis B in Europe boost market growth.

Asia Pacific is estimated to be the fastest growing region for the global hepatitis B treatment market in 2017. A rapidly growing medical diagnostic sector, growing prevalence of bacterial infection and a large number of patients suffering from HIV infection support market growth.

On the other hand, the Middle East and Africa hold the least share in the global hepatitis B treatment market owing to stringent government policies, presence of poor economies, lack of awareness, and low healthcare expenditure within the region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817

Orthobiologics Market To Observe Significant Growth By 2024

 The Global Orthobiologics Market is accounted for USD 4,964 million in 2019 and expected to register 5.6% CAGR during the forecast period (2019–2024).

Orthobiologics are substances that are used by orthopedic surgeons to heal injuries more quickly. The orthobiologics are used to improve the tendons, ligaments, healing of broken bones and injured muscles. Also, these products are derived from substances that are naturally found in the body. When they are used in higher concentrations, orthobiologic substances help speed up the healing process.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7826

The increasing cases of trauma and sports injury, demand for biologics in minimally invasive procedures, approval of products, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period. Moreover, emerging technological innovations in biomaterials, rising obese and geriatric population, and rising research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. For instance, according to the data provided by U.S. Department of Commerce, in 2015, the total population above the age 60 was around 902.28 million, whereas, in 2018, the total population above the age of 60 are around 991.24 million. The population above 60’s year are growing with a rate of 3.18% per years.

However, less reimbursement policy may hamper the growth of the market during the assessment period.

Orthobiologics Market Segmentation

 

The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.

On the basis of product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.

Based on application, the market has been divided into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others. By application spinal fusion segment dominant, the market in 2018 due to increasing sports-related injuries, the prevalence of spine and traumatic injuries, and accidents.

By end user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The orthobiologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European orthobiologics market has been segmented into Western Europe and Eastern Europe. Western Europe has been sub-segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The orthobiologics market in Asia-Pacific has been divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The orthobiologics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

Top Trends In Drug Discovery Informatics Market By 2023

 Global drug discovery informatics market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% during the forecast period. Drug discovery and development is a highly intricate process requiring the generation of very large amounts of data and information. Large amounts of data are generated using a variety of innovative technologies, and the limiting step is accessing, searching and integrating this data. The current approaches to collect information from various sources have been dealt with in some cases where the data types are very least well-defined or largely homogeneous. However, the world is on the verge of a new age of drug discovery informatics, the methods and approaches in which are dealing with gathering information from data and knowledge from information are undergoing a paradigm shift. Mining and integration of domain-specific information such as chemical and genomic data will continue to develop in the near future.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7831

Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process. Some of the factors driving the market growth are a rising worldwide focus on drug discovery, growing need to control drug discovery and development costs, growth in R&D expenditure, and increasing burden of chronic diseases. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. On the other hand, high pricing and setup cost of informatics software is anticipated to restrict the market growth during the forecast period.

Segmentation

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics.

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

The global drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The drug discovery informatics market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European drug discovery informatics market has been segmented into Western Europe and Eastern Europe. The Western Europe drug discovery informatics market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The drug discovery informatics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The drug discovery informatics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Few of the spearheads in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/drug-discovery-informatics-market-7831

Global Healthcare Information Systems Market By Major Industry Trends And Forecast Business Opportunities And Threats In The Next 5 Years

 The global healthcare information systems market is expected to register a CAGR of 10.0% during the forecast period of 2018 to 2023.

Healthcare information technology offers solutions for security and data management of information related with healthcare. Currently, information technology has more effect on the cost quality and safety associated with healthcare. Some commonly used applications in the healthcare industry include electronic medical records, healthcare records and personal health records.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7325

Healthcare Information Systems Market Segmentation

The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.

On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.

Healthcare Information Systems Regional Market Summary

The Americas dominated the global market of healthcare information systems. Rising demand for high quality diagnostics system is the main reason behind the supremacy of the North America’s healthcare information system market. Furthermore, large-scale implementation and storage of electronic records in the healthcare system witnessed in the countries such as Canada and the U.S is supporting the expansion of this regional healthcare information system market.

In 2017, it was estimated that Europe stood second in the global healthcare information systems market. This can be attributed due to the presence of a well-developed healthcare infrastructure, increasing awareness for the condition and presence of developed economies within the region.

Asia Pacific was the fastest growing region for the global healthcare information systems market in 2017. Asia-Pacific has a huge market potential for Healthcare IT industry. India and China are some of the rapidly growing countries, followed by South Korea. Consequently, the government in these rapidly developing economies have taken various efforts to improve healthcare services and provide better infrastructure.

On the other hand, the Middle East and Africa held least share in the global healthcare information systems market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325

Radiofrequency Ablation Devices Market To Show Steady Growth, 2023

 The global radiofrequency ablation devices market is expected to register a CAGR of 11.2% during the forecast period of 2018 to 2023.

Radiofrequency ablation (RFA) uses thermal energy to achieve targeted tissue destruction. Within the GI tract, Radiofrequency ablation was primarily studied for the treatment of dysplastic Barrett’s esophagus (BE), and this continues to be one of the common applications. Indications for Radiofrequency ablation within the GI tract continue to progress. It has been used in the treatment of esophageal squamous cell dysplasia, cholangiocarcinoma, radiation proctopathy, gastric antral vascular ectasia (GAVE), and pancreatic neoplasia, among other conditions.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7634

Radiofrequency ablation devices use an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissue. Electricity travels through tissue between alternating positive and negative poles along the electrode arrays of the radiofrequency ablation device in the radiofrequency range of 450 to 500 kHz.

Segmentation

The global radiofrequency ablation devices market is segmented on the basis of type, application, and region.

On the basis of the type, the global radiofrequency ablation devices market is segmented into Unipolar radiofrequency ablation and Bipolar radiofrequency ablation. By application, the global radiofrequency ablation devices  market is categorized into Surgical Oncology, Cardiology and Cardiac Rhythm Management, Gynecology, Cosmetology, Pain Management

Key players

Some of the key players in the global radiofrequency ablation devices  market are Boston scientific corporation, Medtronic Inc, Stryker, Cosman Medical, Inc., St. Jude Medical, Smith & Nephew, Johnson & Johnson (J&J) Services, LLC, Angiodynamics, RF Medical Co, Ltd, AtriCure, Inc., and others

Regional Market 

The Americas dominates the global market for radiofrequency ablation devices owing a growing number of lung cancer cases like, Non-Small Cell Lung Cancer (NSCLC) which is the most common type of lung cancer, accounting for 80-85% of all lung cancer cases. It is generally a slow growing and spreading as compared to small cell lung cancer (SCLC). Small cell lung cancer used to account for 12-13% of lung cancers. However, there has been a shift from NSCLC to SCLC in recent years which has propelled the growth of the radiofrequency ablation devices market.

In 2017, it was estimated that Europe stood second in the global radiofrequency ablation devices market.

Asia-Pacific was the fastest growing region for the global radiofrequency ablation devices market in 2017. Factors such as increasing awareness of the cardiac disease, growing healthcare industries, and the development of various treatment methods for gynecology and cosmetology drives the market in this region.

On the other hand, the Middle East and Africa holds the least share in the global radiofrequency ablation devices market. The presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/radiofrequency-ablation-devices-market-7634